Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Pharmacovigilance Conference"

21:48 EDT 18th April 2014 | BioPortfolio

Matching Channels

BioPortfolio - life science, medical devices and pharmaceutical conference

BioPortfolio is an internet agent for Visiongain's life science, medical devices and pharmaceutical conference.

Management Forum - highest quality conference, seminar and knowledge-based experiences

Since 1983, Management Forum have built a reputation on providing the highest quality conference, seminar and knowledge-based experiences for leading professionals in some of the world's most...

Matching News

4th Pharmacovigilance, Risk Management & AER Conference, 6-7 May 2014, Philadelphia

Developing Proactive Pharmacovigilance and Risk Management StrategiesTop Pharmaceutical and Biotech Representatives to Discuss the Current Complexities and Key Challenges in Pharmacovigilance, May 6-7...

EU Pharmacovigilance & Risk Management, 13th & 14th March 2014, Vienna

The legislation is now supported with comprehensive Pharmacovigilance modules that Affect Pharmacovigilance; Regulatory; Medical Information; QA; Clinical as well affecting the Senior Management view...

EU Sets The Stage For Increased Pharmacovigilance Oversight And Harmonization

With the overarching goal of improving transparency and accountability, the European Medicines Agency (EMA) has been taking a more comprehensive approach to pharmacovigilance, introducing a set of goo...

Download whitepaper: Pharmacovigilance Outsourcing

  Over the past several years pharmaceutical companies have evaluated the cost of performing pharmacovigilance operations with a critical eye. Global regulatory requirements have continually incr...

Europe’s health care industry calls for balanced and transparent funding of the EU pharmacovigilance system

Five European health care trade groups say they support the implementation of an effective pharmacovigilance system to ensure patient safety and recognize recent efforts which have been made to ensure...

Developing Proactive Pharmacovigilance and Risk Management Strategies

PHILADELPHIA, PA -- (Marketwired) -- 03/25/14 -- marcus evans will host the 4th Pharmacovigilance, Risk Management & AER Conference, May 6-7, 2014 in Philadelphia, PA. The meeting will address...

Global Pharmacovigilance Services Market to Grow at 13% CAGR from 2013 to 2019

The contract outsourcing services will countinue to dominate the total market for pharmacovigilance.

Pharmacovigilance: ADR Management and Reporting & Outsourcing Trends, A New Drug Safety Webinar from Xtalks

Toronto, Canada (PRWEB) November 22, 2013 Join Dr. Marcin Marciniak, Director Drug Safety & Pharmacovigilance, PregLem SA, and member of Gedeon Richter Group and Dr. Philip Jones, BMBS, MA, MSc...

Matching PubMed Articles

Pharmacovigilance in Italy: An overview.

Spontaneous reporting of adverse drug reactions (ADRs) is the basis of pharmacovigilance. In fact, ADRs are associated with a high degree of morbidity and mortality. However, underreporting by all hea...

An evaluation of knowledge of pharmacovigilance among nurses and midwives in Turkey.

This study aimed to evaluate the awareness of nurse/midwives regarding pharmacovigilance as well as their knowledge and experience in identifying and reporting adverse reactions of drugs. Nurse/midwiv...

Informatics applied to pharmacovigilance: Future perspectives.

Spontaneous adverse drugs reaction (ADRs) reporting represents a precious resource for control and information about the drug's safety and pharmacovigilance. The current reporting system is mainly bas...

Pharmacovigilance in Asia.

An increase in drug safety concerns in recent years with some high profile drug withdrawals have led to raising the bar by various stakeholders more importantly by the regulatory authorities. The numb...

Beriate(®) P in the treatment of patients with haemophilia A: Results of a long-term pharmacovigilance study.

The German Beriate(®) P pharmacovigilance study started in 2003 and is planned to run until December 2013.

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement